UPDATE: William Blair Starts Lifestance Health Group (LFST) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Morgan Stanley Starts Lifestance Health Group (LFST) at Overweight
July 6, 2021 12:52 AM EDTMorgan Stanley analyst Ricky Goldwasser initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.
The analyst comments "We apply a 11.5x EV/22revenue multiple to our base case 2023 $1.2b revenue estimate,a +1x turn... More
JPMorgan Starts Lifestance Health Group (LFST) at Overweight
July 6, 2021 12:50 AM EDTJPMorgan analyst Lisa Gill initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.
The analyst comments "The largest outpatient behavioral health platform in the U.S., LifeStance aims to disrupt the traditional model which suffers from: 1) low... More
UPDATE: Jefferies Starts Lifestance Health Group (LFST) at Buy
July 5, 2021 10:36 PM EDT(Updated - July 6, 2021 7:20 AM EDT)
Jefferies analyst Stephanie Wissink initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Buy rating and a price target of $36.00.
The analyst commented, "We are initiating coverage of LifeStance at Buy, backed by its leading... More
Goldman Sachs Starts Lifestance Health Group (LFST) at Neutral
July 5, 2021 10:34 PM EDTGoldman Sachs analyst Jamie Perse initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Neutral rating and a price target of $25.00.
The analyst comments "LifeStance is a leading provider of outpatient mental health services focused on reducing barriers to treatment. LFST... More
